Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the use of a urine test strip in diagnose schistosoma mansoni in areas of Kenya where the rate of infections are low.

The hypothesis is that the urine strip test is a superior tool to the conventional parasitological tools used to diagnose schistosomiasis mansoni infections in area where there is low transmission


Clinical Trial Description

The study will compare the use of the urine test strip with the conventional method used and with a "golden standard" methode, in an area of Kenya where the infection transmission is low. Furthermore will the urine test strip be evaluatied in its ability to monitor the intensity of infections in school children before and after they are been treated for the infections.

A total of 1100 school children in the age between 10 and 18 years will be included in the study. Children have to submitt a stool and a urine sample on three consecutive days. Children who are found to be infected with the schistosomiasis parasite will be offered treatment. ;


Study Design

N/A


Related Conditions & MeSH terms


NCT number NCT00463307
Study type Observational
Source DBL -Institute for Health Research and Development
Contact
Status Completed
Phase N/A
Start date April 2006
Completion date November 2006

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06055530 - Evaluation of an AI-DP for STH Deworming Programs: a Study Protocol
Completed NCT02878564 - Effect of Schistosomiasis Mansoni on HIV Susceptibility and Female Genital Immunology Phase 4
Completed NCT00403611 - Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in Brazil Phase 4
Active, not recruiting NCT05788003 - Female Genital Schistosomiasis in Tanzania N/A
Recruiting NCT05658614 - Anti-Schistosomiasis Sm14-vaccine in Senegal Phase 2
Completed NCT01931826 - Treatment Schistosomal Portal Hypertension: Efficacy of Endoscopy or Surgery N/A
Recruiting NCT03640377 - Praziquantel in Children Under Age 4 Phase 2
Completed NCT01529710 - Safety and Efficacy of Mirazid for Schistosomiasis Treatment Phase 3
Completed NCT04269915 - Single-sex Female Controlled Human Schistosomiasis Mansoni Infection N/A